Verastem, Inc. (VSTM)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Verastem, Inc. (VSTM)
Go deeper and ask any question about VSTM
Company Performance
Current Price
as of Sep 13, 2024$2.81
P/E Ratio
N/A
Market Cap
$113.08M
Description
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Metrics
Overview
- HQNeedham, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerVSTM
- Price$2.81+1.44%
Trading Information
- Market Cap$113.08M
- Float91.31%
- Average Daily Volume (1m)443,460
- Average Daily Volume (3m)630,071
- EPS-$3.34
Company
- Revenue$10.00M
- Rev Growth (1yr)N/A
- Net Income-$8.26M
- Gross Margin99.94%
- EBITDA Margin-182.71%
- EBITDA-$18.27M
- EV$59.70M
- EV/Revenue5.97
- P/EN/A
- P/S7.55
Documents
SEC Filings
Factset Street Account
Wikipedia